TrialResults-center.org

Menu

Description Results NMA

Group by...

in first

in second

in third

pdf

pathology

Demonstrated benefit and harm

k

peripheral vascular diseases

versus placebo or control

No demonstrated result for efficacy

Trial	control	p<0.05	harm	NS
Bauer, 1984	ginko biloba vs placebo
Peters, 1998	ginko biloba vs placebo

Trial

Treatments

Patients

Method

Bauer, 1984

ginko biloba 40 mg three times daily (n=44)

vs.

placebo (n=35)

AOMI stade IIb

Double aveugle

Parallel groups

Sample size: 44/35

Primary endpoint: amélioration subjective symptomes

FU duration: 6 mois

Peters, 1998

ginko biloba EGb 761 three times daily (n=53)

vs.

placebo (n=58)

AOMI stade IIb

Double aveugle

Parallel groups

Sample size: 53/58

Primary endpoint: périmètre de marche

FU duration: 6 mois

Modal title

- About - Browse pathology | treatment - Site map - Credits Made with in Lyon - Contact us - Privacy policy -